These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
256 related items for PubMed ID: 9401775
1. The influence of 5-HT2 and 5-HT4 receptor antagonists to modify drug induced disinhibitory effects in the mouse light/dark test. Costall B, Naylor RJ. Br J Pharmacol; 1997 Nov; 122(6):1105-18. PubMed ID: 9401775 [Abstract] [Full Text] [Related]
2. Profiles of interaction of R(+)/S(-)-zacopride and anxiolytic agents in a mouse model. Barnes NM, Cheng CH, Costall B, Ge J, Kelly ME, Naylor RJ. Eur J Pharmacol; 1992 Jul 21; 218(1):91-100. PubMed ID: 1356807 [Abstract] [Full Text] [Related]
3. Behavioural interactions between 5-hydroxytryptophan, neuroleptic agents and 5-HT receptor antagonists in modifying rodent responding to aversive situations. Costall B, Naylor RJ. Br J Pharmacol; 1995 Dec 21; 116(7):2989-99. PubMed ID: 8680734 [Abstract] [Full Text] [Related]
4. Actions of 5-hydroxytryptophan to inhibit and disinhibit mouse behaviour in the light/dark test. Cheng CH, Costall B, Kelly ME, Naylor RJ. Eur J Pharmacol; 1994 Apr 01; 255(1-3):39-49. PubMed ID: 7913044 [Abstract] [Full Text] [Related]
5. Combined blockade of 5-HT3- and 5-HT4-serotonin receptors inhibits colonic functions in conscious rats and mice. Nagakura Y, Kontoh A, Tokita K, Tomoi M, Shimomura K, Kadowaki M. J Pharmacol Exp Ther; 1997 Apr 01; 281(1):284-90. PubMed ID: 9103508 [Abstract] [Full Text] [Related]
6. Modulation by 5-HT1A receptors of the 5-HT2 receptor-mediated tachykinin-induced contraction of the rat trachea in vitro. Germonpré PR, Joos GF, Pauwels RA. Br J Pharmacol; 1998 Apr 01; 123(8):1571-8. PubMed ID: 9605563 [Abstract] [Full Text] [Related]
7. Dual role of serotonin in the pathogenesis of indomethacin-induced small intestinal ulceration: pro-ulcerogenic action via 5-HT3 receptors and anti-ulcerogenic action via 5-HT4 receptors. Kato S, Matsuda N, Matsumoto K, Wada M, Onimaru N, Yasuda M, Amagase K, Horie S, Takeuchi K. Pharmacol Res; 2012 Sep 01; 66(3):226-34. PubMed ID: 22699012 [Abstract] [Full Text] [Related]
8. Analysis of the 5-HT1A receptor involvement in passive avoidance in the rat. Misane I, Johansson C, Ogren SO. Br J Pharmacol; 1998 Oct 01; 125(3):499-509. PubMed ID: 9806333 [Abstract] [Full Text] [Related]
9. The pharmacology of the 5-HT4 receptor. Costall B, Naylor RJ. Int Clin Psychopharmacol; 1993 Nov 01; 8 Suppl 2():11-8. PubMed ID: 8201242 [Abstract] [Full Text] [Related]
10. Participation of a cholinergic mechanism in 5-hydroxytryptamine (5-HT)3 and 5-HT4 receptor-mediated stimulation of gastric emptying in rats. Yamano M, Kamato T, Miyata K. Arzneimittelforschung; 1997 Nov 01; 47(11):1242-6. PubMed ID: 9428982 [Abstract] [Full Text] [Related]
11. Effects of agonists and antagonists of some serotonin-receptor subtypes on memory and their modulation by the 5-HT-uptake inhibitor fluoxetine. Petkov VD, Kehayov R. Acta Physiol Pharmacol Bulg; 1994 Nov 01; 20(3-4):83-90. PubMed ID: 7645408 [Abstract] [Full Text] [Related]
13. GR113808: a novel, selective antagonist with high affinity at the 5-HT4 receptor. Gale JD, Grossman CJ, Whitehead JW, Oxford AW, Bunce KT, Humphrey PP. Br J Pharmacol; 1994 Jan 01; 111(1):332-8. PubMed ID: 8012715 [Abstract] [Full Text] [Related]
19. 5-HT4 receptor-mediated modulation of 5-HT release in the rat hippocampus in vivo. Ge J, Barnes NM. Br J Pharmacol; 1996 Apr 01; 117(7):1475-80. PubMed ID: 8730742 [Abstract] [Full Text] [Related]
20. Role of the 5-HT2 receptor in the methamphetamine-induced neurochemical alterations. Johnson M, Sonsalla PK, Letter AA, Hanson GR, Gibb JW. J Pharmacol Exp Ther; 1994 Jul 01; 270(1):97-103. PubMed ID: 7913500 [Abstract] [Full Text] [Related] Page: [Next] [New Search]